BioStem director exercises 5,647 RSUs to shares

BioStem Technologies, Inc. (BSEM) director Jodi Ungrodt reported the vesting and exercise of restricted stock units into common stock.

Rhea-AI Filing Summary

BioStem Technologies, Inc. (BSEM) director Jodi Ungrodt reported the vesting and exercise of restricted stock units into common stock. On August 27, 2026, 5,647 restricted stock units, each representing a contingent right to one common share, were converted into 5,647 shares of common stock. Following this transaction, Ungrodt directly held 11,295 shares of common stock and no remaining restricted stock units from this grant, which had vested in two installments on May 27, 2026 and August 27, 2026.

Insider Trade Summary

5,647 shares exercised/converted

Exercise 2 txns

Insider UNGRODT JODI

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units F1, F2	5,647	$0.00	$0.00
Exercise	Common Stock	5,647	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 0 contracts (Direct); Common Stock — 11,295 shares (Direct)

Footnotes (2)

1. F1. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
2. F2. These restricted stock units vest in two installments. The first installment vested on May 27, 2026, and the remaining installment vested on August 27, 2026.

Key Figures

Restricted stock units exercised: 5,647 units Common shares acquired via RSU conversion: 5,647 shares Common shares held after transaction: 11,295 shares +2 more

5 metrics

Restricted stock units exercised 5,647 units Restricted Stock Units converted into common stock on August 27, 2026

Common shares acquired via RSU conversion 5,647 shares Common Stock received upon RSU exercise on August 27, 2026

Common shares held after transaction 11,295 shares Direct ownership after August 27, 2026 transaction

RSU transaction price per share $0.00 per share Reported exercise price for RSU conversion on August 27, 2026

RSU vesting dates May 27, 2026 and August 27, 2026 Two-installment vesting schedule for these restricted stock units

Key Terms

Restricted Stock Units, contingent right, vest, Exercise or conversion of derivative security

4 terms

Restricted Stock Units financial

"Each restricted stock unit represents a contingent right to receive one share"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"represents a contingent right to receive one share of the issuer's common"

vest financial

"These restricted stock units vest in two installments"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

Exercise or conversion of derivative security financial

"transaction_code_description: Exercise or conversion of derivative security"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did BSEM director Jodi Ungrodt report on August 27, 2026?

Ungrodt reported the vesting and exercise of 5,647 restricted stock units into 5,647 shares of BioStem Technologies, Inc. common stock on August 27, 2026, as part of an equity award that vested in two installments.

How many BioStem Technologies (BSEM) shares does Jodi Ungrodt hold after this Form 4?

After the reported transactions, Jodi Ungrodt directly holds 11,295 shares of BioStem Technologies, Inc. common stock as of August 27, 2026.

What happened to Jodi Ungrodt’s restricted stock units in BSEM reported in this filing?

The filing shows 5,647 restricted stock units were exercised and converted into 5,647 common shares. The units from this grant vested in two installments, on May 27, 2026 and August 27, 2026, leaving no units from this award after conversion.

Were the BSEM restricted stock units granted to Jodi Ungrodt tied to common stock?

Yes. Each restricted stock unit represented a contingent right to receive one share of BioStem Technologies, Inc. common stock, according to the footnote in the Form 4.

Does this BSEM Form 4 show a market purchase or sale by Jodi Ungrodt?

No market purchase or sale is shown. The Form 4 reports a code M exercise/conversion of 5,647 restricted stock units into 5,647 shares, with a reported transaction price of $0.00 per share for the exercise.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/28/2026 - 04:15 PM EDT Accepted by SEC EDGAR 08/28/2026 - 04:15 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

UNGRODT JODI

(Last) (First) (Middle)

C/O BIOSTEM TECHNOLOGIES, INC.

2836 CENTER PORT CIRCLE

(Street)

POMPANO BEACH FLORIDA 33064

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BioStem Technologies, Inc. [ BSEM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/27/2026		M		5,647	A	$0.00	11,295	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	08/27/2026		M			5,647	(2)	(2)	Common Stock	5,647	$0.00	0	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

2. These restricted stock units vest in two installments. The first installment vested on May 27, 2026, and the remaining installment vested on August 27, 2026.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Katherine Gorrell, Attorney-in-Fact	08/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)